HIF1A and cancer: Various cancers include liver, breast, cervix, and oropharynx all overexpressed HIF-1α and its overexpression often positively leads to poor prognosis.[9] Liu et al[10] found that significantly higher positive rates (73%) of HIF-1α were observed in PTC compared with the control group (27%) by immunohistochemistry (IHC).